Advanced Oncotherapy – Result of AGM
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed. For further information contact: Advanced Oncotherapy Plc www.avoplc.com Sanjeev Pandya, CEO Tel: +44 20 3617 8728 Nicolas Serandour, CFO Westhouse Securities (Nomad & Joint Broker) Antonio Bossi […]
Advanced Oncotherapy – Proton radiation zaps US wallets.
Proton radiation zaps US wallets. By Melinda Beck Six new proton-beam centres are set to start delivering state-ofthe-art radiation to cancer patients around the country by year’s end. Ten more are expected by 2018, bringing the US total to 30 Link here for full article
Advanced Oncotherapy – Large increase in pediatric patients treated with proton therapy
From Oncology Nurse Advisor: Results from a new nationwide survey indicate a steady increase in the number of pediatric patients who are being treated with proton radiation therapy for cancerous and noncancerous tumors. The research was presented during the 54th Annual Conference of the Particle Therapy Co-Operative Group (PTCOG). Based on a survey of all […]
Advanced Oncotherapy – Men should have open dialogue about screening, treatment for prostate cancer
Men should have open dialogue about screening, treatment for prostate cancer By Michaela Morris in Health, Lifestyle, Daily Journal Dick Guyton is glad he made the decision to continue with prostate cancer screening. After being diagnosed with early stage disease in May 2013, he took his time and gathered all the options for treatment […]
Advanced Oncotherapy – Mayo Clinic: Proton beam therapy useful against many types of cancer
DEAR MAYO CLINIC: What does proton beam therapy do for cancer patients that standard radiation therapy doesn’t do? How do doctors decide when to use proton beam therapy? ANSWER: Proton beam therapy is a type of radiation therapy used to treat cancer. Unlike standard radiation therapy using X-rays, which travel all the way through a […]
Advanced Oncotherapy – CEO, CFO & Non-Exec director purchase shares in the company
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Sanjeev Pandya, Chief Executive Officer, and Nicolas Serandour, Chief Financial Officer, informed the Company on 5 June 2015 that they individually purchased 220,000 ordinary shares of 1 penny each in the Company at 9 pence per Ordinary Share on that […]
Advanced Oncotherapy – Director Dealing
Advanced Oncotherapy announces that Michael Sinclair, Executive Chairman of the Company, had yesterday purchased an option over 30 million ordinary shares of 1 penny each in the Company from Brahma AG at a cost of £300,000. The Option vests immediately, expires two years from today’s date and has an exercise price of 10p per Ordinary Share. […]
Advanced Oncotherapy (AVO) – Final Results for the year ended 31 December 2014
Advanced Oncotherapy (AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 December 2014, a year of significant progress in the development of the Company’s LIGHT system. A number of key milestones in the development of the LIGHT system have also been completed following the […]
International Medical Journal – Apollo to get first proton therapy centre in the region
South Asia’s first proton therapy treatment is coming soon at Apollo Hospitals. Proton therapy will provide Apollo’s team of oncologists another critical tool in the fight against cancer. Proton therapy is an advanced form of radiation therapy that uses beams of high-energy protons rather than traditional X-rays to irradiate a tumour. The protons are precisely […]
New survey shows 36-percent increase in pediatric patients treated with proton therapy
Most pediatric proton patients are younger than 10, with brain and spinal cord tumors Results from a new nationwide survey indicate a steady increase in the number of pediatric patients who are being treated with proton radiation therapy for cancerous and non-cancerous tumors. The research, led by Andrew L. Chang, M.D., medical director of pediatrics […]